NeoGenomics NEO Reportable Segment — Operating Income (Loss)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about NeoGenomics's reportable segment — operating income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is NeoGenomics's reportable segment — operating income (loss)?
- NeoGenomics (NEO) reported reportable segment — operating income (loss) of -$18.24M in Q1 2026.
- How has NeoGenomics's reportable segment — operating income (loss) changed year-over-year?
- NeoGenomics's reportable segment — operating income (loss) increased by 34.4% year-over-year, from -$27.83M to -$18.24M.
- What is the long-term trend for NeoGenomics's reportable segment — operating income (loss)?
- Over 3 years (2022 to 2025), NeoGenomics's reportable segment — operating income (loss) has grown at a -9.7% compound annual growth rate (CAGR), from -$157.62M to -$115.88M.
- What does reportable segment — operating income (loss) mean?
- The profit or loss generated by the segment after subtracting all operating expenses from net revenue. It is the fundamental measure of the segment's core operational profitability and financial viability.